Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2024 | Story Leonie Bolleurs | Photo Supplied
BOOTES-6 telescope station
The BOOTES-6 telescope station captured a South African sighting of the southern lights, a rare atmospheric phenomenon powered by solar activity.

The northern lights, with their vibrant displays of green, pink, and violet hues, have become a famous attraction in Nordic countries. But in early October, a rare sighting of the southern lights – or aurora australis – was reported in South Africa, surprising many.

Prof Pieter Meintjes, Professor in the Department of Physics at the University of the Free State (UFS), explains that both the northern and southern lights are the result of charged particles from coronal mass ejections (CMEs) on the sun, which are captured by Earth’s magnetic field. "The interaction between magnetic fields and charged particles, such as protons and electrons, is very interesting. The magnetic field forces these particles to spiral around the field lines, ultimately guiding them towards the magnetic poles. As these particles enter Earth’s atmosphere, they collide with atmospheric atoms, causing a beautiful glow. The colours of the aurora indicate which atoms are involved. Typically, hydrogen shines red, while oxygen and nitrogen produce a greenish-blue tinge," he says.

Observing the southern lights

When the display occurs above the northern magnetic pole, it is called the aurora borealis (northern lights) and can typically be observed over regions such as Alaska, Greenland, and the Nordic countries. Above the southern magnetic pole, it is known as aurora australis (southern lights), usually visible over places such as Antarctica and New Zealand. “In extreme cases – when gigantic mass ejections occurred – it can also be observed in mid-latitudes such as South Africa,” says Prof Meintjes.

This recent and rare South African sighting was also captured by the BOOTES-6 telescope station at Boyden Observatory, located just outside Bloemfontein. According to Prof Meintjes, the telescope station has an all-sky monitor – a camera constantly watching the sky for changes and monitoring, among others, cloud cover to ensure that the telescope is always safe from weather. While the monitor was taking photos of the night sky, Prof Alberto Castro-Tirado, a research professor at the Institute of Astrophysics of Andalusia in Spain, picked up the aurora.

The Institute of Astrophysics of Andalusia in Spain, in collaboration with the University College Dublin (UCD), is partnering with the UFS in a research-driven initiative involving the BOOTES-6 telescope station, installed in 2022 during the COVID-19 pandemic. Under a Memorandum of Understanding that was recently renewed for another five years, the UFS and UCD share approximately 30% of the telescope's observing time dedicated to UFS research.

“The DPRT telescope (Dolores Pérez-Ramírez telescope), named after a Spanish astronomer and lecturer at the University of Jaén, contributes significantly to our research, with publications resulting from contributions made by the telescope station and collaborators on gamma-ray bursts, occultations, and transient events co-authored by me and a colleague in the department, Dr Hendrik van Heerden,” notes Prof Meintjes.

Research-driven initiatives

Data from the telescope station is also used for their in-house projects and contributes significantly to the work of their PhD students that will be submitted in the next few years. This includes the PhD work of Helene Szegedi, who uses data from the BOOTES-6 telescope station to study cataclysmic variable systems – compact binaries that erupt regularly. Another PhD student, Joleen Barnard, studies blazar variability under the guidance of Prof Brian van Soelen. Blazars, explains Prof Meintjes, are the core of distant galaxies powered by supermassive black holes. These cosmic jets are pointed towards Earth, but fortunately, they are millions or billions of light years away; otherwise, their impact would be devastating to life on Earth.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept